Delivery Order SPE2DB22D2009-SPE2DB25FL8PT

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 36 mg tablets in 100-count packages. The $1,897.26 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the company to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.76 firm fixed-price delivery order is for the supply of 4,567,027,775 units of Methylphenidate ER 36 mg tablets in 100-count bottles. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,122,144 units of Methylphenidate ER 36 mg tablets in 100-count bottles. The firm-fixed-price delivery order, valued at $1,183.58, has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA). The $1,554.11 firm-fixed-price delivery order has a completion date of November 13, 2024 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.33 firm fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 36 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate ER 18 mg tablets. The $3,473.04 firm fixed-price delivery order has a period of performance through February 19, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
This federal contract award is for the delivery of 4,565,153,933 tablets of Methylphenidate ER 36mg to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $4,943.66 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of medical products to DoD facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,691.09 firm fixed-price delivery order is for the supply of 4,565,069 units of Methylphenidate ER 36 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $1,398.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 36 mg tablets, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,084.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylphenidate ER 36 mg tablets. The contract has a firm fixed price and a completion date of March 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8PT
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,031.76 for Methylphenidate ER 36 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is not designated as a set-aside.

The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/1/25, 8:02 AM